Home > Blog

4 min read

Regulatory Guidance Monthly Review - September 2019

September 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...

READ MORE

2 min read

What Matters Most in the Clinical Study Feasibility Process

Site Selection to Protocol Development: An Approach to the Feasibility Process

How does the site feasibility study process work at Veristat? 

Our process starts from the RFP stage. We usually send a feasibility questionnaire to the site prior to the...

READ MORE

3 min read

Regulatory Guidance Monthly Review - August 2019

August 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...

READ MORE

2 min read

Regulatory Guidance Monthly Review - July 2019

July 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic,...

READ MORE

2 min read

Regulatory Guidance Monthly Review - June 2019

June 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic,...

READ MORE

2 min read

Regulatory Guidance Review - May 2019

May 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) and European Medicines Agency (EMA) that are pertinent to the governance of...

READ MORE

2 min read

Regulatory Guidance Review - April 2019

Latest Updates from FDA & EMA

April 2019 Updates

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) and European Medicines Agency (EMA) that are pertinent...

READ MORE

4 min read

5 Ways To Transform Your Workspace For Inspiration and Creativity

It’s mid-afternoon on a Thursday, and you’re at your desk. You have important work to do, but your attention is wandering, and you can’t seem to get the motivation you need to get anything done.

READ MORE

2 min read

Regulatory Guidance Review

Latest Updates from FDA & EMA

March 2019

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) and European Medicines Agency (EMA) that are pertinent to the...

READ MORE

4 min read

5 Best Practices for Making Virtual Teams Work

At Veristat our need to manage and work in virtual environments continues to increase. With six offices globally and nearly 300 employees, we are building teams with members spread out in different physical locations. Our geographically dispersed teams...

READ MORE